Literature DB >> 32193190

Comparison of Enhancement of the Vestibular Perilymph between Variable and Constant Flip Angle-Delayed 3D-FLAIR Sequences in Menière Disease.

S Nahmani1, A Vaussy2, C Hautefort3, J-P Guichard1, A Guillonet1, E Houdart1, A Attyé4, M Eliezer5.   

Abstract

BACKGROUND AND
PURPOSE: Endolymphatic hydrops in patients with Menière disease relies on delayed postcontrast 3D-FLAIR sequences. The purpose of this study was to compare the degree of perilymphatic enhancement and the detection rate of endolymphatic hydrops using constant and variable flip angles sequences.
MATERIALS AND METHODS: This was a retrospective study performed in 16 patients with Menière disease who underwent 3T MR imaging 4 hours after gadolinium injection using two 3D-FLAIR sequences with a constant flip angle at 140° for the first and a heavily-T2 variable flip angle for the second. The signal intensity ratio was measured using the ROI method. We graded endolymphatic hydrops and evaluated the cochlear blood-labyrinth barrier impairment.
RESULTS: Both for symptomatic and asymptomatic ears, the median signal intensity ratio was significantly higher with the constant flip angle than with the heavily-T2 variable flip angle (7.16 versus 1.54 and 7.00 versus 1.45, P < .001). Cochlear blood-labyrinth barrier impairment was observed in 4/18 symptomatic ears with the heavily-T2 variable flip angle versus 8/19 with constant flip angle sequences. With heavily-T2 variable flip angle sequences, endolymphatic hydrops was observed in 7-10/19 symptomatic ears versus 12/19 ears with constant flip angle sequences. We found a significant association between the clinical symptomatology and the presence of endolymphatic hydrops with constant flip angle but not with heavily-T2 variable flip angle sequences. Interreader agreement was always perfect with constant flip angle sequences while it was fair-to-moderate with heavily-T2 variable flip angle sequences.
CONCLUSIONS: 3D-FLAIR constant flip angle sequences provide a higher signal intensity ratio and are superior to heavily-T2 variable flip angle sequences in reliably evaluating the cochlear blood-labyrinth barrier impairment and the endolymphatic space.
© 2020 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32193190      PMCID: PMC7144642          DOI: 10.3174/ajnr.A6483

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  30 in total

1.  Optimized three-dimensional fast-spin-echo MRI.

Authors:  John P Mugler
Journal:  J Magn Reson Imaging       Date:  2014-01-08       Impact factor: 4.813

2.  Committee on Hearing and Equilibrium guidelines for the evaluation of results of treatment of conductive hearing loss. AmericanAcademy of Otolaryngology-Head and Neck Surgery Ffoundation, Inc.

Authors: 
Journal:  Otolaryngol Head Neck Surg       Date:  1995-09       Impact factor: 3.497

3.  Delayed intravenous contrast-enhanced 3D FLAIR MRI in Meniere's disease: correlation of quantitative measures of endolymphatic hydrops with hearing.

Authors:  Ali R Sepahdari; Gail Ishiyama; Nopawan Vorasubin; Kevin A Peng; Michael Linetsky; Akira Ishiyama
Journal:  Clin Imaging       Date:  2014-10-16       Impact factor: 1.605

4.  Comprehensive comparison of MR image quality between intratympanic and intravenous gadolinium injection using 3D real IR sequences.

Authors:  Yang Li; Yan Sha; Feng Wang; Ping Lu; Xilan Liu; Yaru Sheng; Zhongshuai Zhang; Mengxiao Liu
Journal:  Acta Otolaryngol       Date:  2019-05-25       Impact factor: 1.494

5.  Long-term results of vestibular nerve section.

Authors:  A K Tewary; N Riley; A G Kerr
Journal:  J Laryngol Otol       Date:  1998-12       Impact factor: 1.469

6.  Detection of intralabyrinthine abnormalities using post-contrast delayed 3D-FLAIR MRI sequences in patients with acute vestibular syndrome.

Authors:  Michael Eliezer; Charles Maquet; Julien Horion; André Gillibert; Michel Toupet; Benoit Bolognini; Nicolas Magne; Laureline Kahn; Charlotte Hautefort; Arnaud Attyé
Journal:  Eur Radiol       Date:  2018-11-09       Impact factor: 5.315

7.  Increased sensitivity to low concentration gadolinium contrast by optimized heavily T2-weighted 3D-FLAIR to visualize endolymphatic space.

Authors:  Shinji Naganawa; Hisashi Kawai; Michihiko Sone; Tsutomu Nakashima
Journal:  Magn Reson Med Sci       Date:  2010       Impact factor: 2.471

8.  Comparison of contrast effect on the cochlear perilymph after intratympanic and intravenous gadolinium injection.

Authors:  M Yamazaki; S Naganawa; M Tagaya; H Kawai; M Ikeda; M Sone; M Teranishi; H Suzuki; T Nakashima
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-15       Impact factor: 3.825

9.  Comparison of enhancement of the vestibular perilymph between gadoterate meglumine and gadobutrol at 3-Tesla in Meniere's disease.

Authors:  M Eliezer; G Poillon; A Gillibert; J Horion; Y Cruypeninck; E Gerardin; N Magne; A Attyé
Journal:  Diagn Interv Imaging       Date:  2018-02-15       Impact factor: 4.026

10.  Meniere's disease: a reappraisal supported by a variable latency of symptoms and the MRI visualisation of endolymphatic hydrops.

Authors:  Ilmari Pyykkö; Tsutomu Nakashima; Tadao Yoshida; Jing Zou; Shinji Naganawa
Journal:  BMJ Open       Date:  2013-02-14       Impact factor: 2.692

View more
  3 in total

1.  A Perspective for Ménière's Disease: In Silico Investigations of Dexamethasone as a Direct Modulator of AQP2.

Authors:  Robin Mom; Julien Robert-Paganin; Thierry Mom; Christian Chabbert; Stéphane Réty; Daniel Auguin
Journal:  Biomolecules       Date:  2022-03-28

2.  Intravenous Delayed Gadolinium-Enhanced MR Imaging of the Endolymphatic Space: A Methodological Comparative Study.

Authors:  Rainer Boegle; Johannes Gerb; Emilie Kierig; Sandra Becker-Bense; Birgit Ertl-Wagner; Marianne Dieterich; Valerie Kirsch
Journal:  Front Neurol       Date:  2021-04-22       Impact factor: 4.003

3.  Comparison between 3D SPACE FLAIR and 3D TSE FLAIR in Menière's disease.

Authors:  Anja Bernaerts; Nick Janssen; Floris L Wuyts; Cathérine Blaivie; Robby Vanspauwen; Joost van Dinther; Andrzej Zarowski; Erwin Offeciers; Filip Deckers; Jan W Casselman; Bert De Foer
Journal:  Neuroradiology       Date:  2022-02-12       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.